MIRAGEN THERAPEUTICS, INC. (44) | Uncategorized (9)

Recent Contracts

Open Market Sale Agreement, dated April 23, 2021, by and between Viridian Therapeutics, Inc. and Jefferies LLC (Filed With SEC on April 26, 2021)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 26, 2021)
Amendment to Research Subaward Agreement, entered into as of August 11, 2020, by and between Registrant and Yale University (Filed With SEC on November 12, 2020)
Fourth Addendum to Lease by and between Registrant and Crestview, LLC, dated as of April 7, 2020 (Filed With SEC on May 8, 2020)
Amendment to Research Subaward Agreement, entered into as of April 7, 2020, by and between Registrant and Yale University (Filed With SEC on May 8, 2020)
Deferral Agreement between Silicon Valley Bank and the Registrant effective as of April 6, 2020 (Filed With SEC on May 8, 2020)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 13, 2020)
Amendment to Research Subaward Agreement, entered into as of October 11, 2019 and effective as of August 12, 2019, by and between Registrant and Yale University, as amended (Filed With SEC on November 8, 2019)
Amendment to Research Subaward Agreement, entered into as of March 7, 2019 and effective as of September 1, 2018, by and between Registrant and Yale University, as amended (Filed With SEC on May 9, 2019)